Tool
Stock screener
Filter the 3753 US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.
Top Quant-ratedLarge-cap dividend payersCheap & top-ratedBeaten-down (down 20%+ 1yr)High yield (4%+)Mega-cap winners
9 matches
| Company | 60d | Last | Chg% | Mkt cap | P/E | Yield | 1-yr | Quant ↓ |
|---|---|---|---|---|---|---|---|---|
| Organon & CoOGN | 13.87 | +0.58% | $3.64B | 17.78 | 0.58% | +106.2% | B 97 | |
| BiogenBIIB | 248.35 | +1.81% | $36.71B | 107.51 | -- | +59.7% | B 90 | |
| AmgenAMGN | 460.42 | +0.03% | $249.05B | 26.69 | 2.16% | +47.8% | B 85 | |
| Gilead SciencesGILD | 166.89 | -0.41% | $207.00B | -- | 1.95% | +43.1% | B 79 | |
| PfizerPFE | 29.39 | -0.20% | $167.52B | 41.99 | 5.85% | +26.5% | C 69 | |
| GlaxoSmithKlineGSK | 50.33 | -0.16% | $100.88B | 17.50 | 3.56% | +11.8% | D 50 | |
| SanofiSNY | 47.04 | +0.28% | $112.71B | 24.10 | 4.99% | -0.0% | C 37 | |
| GrifolsGRFS | 8.43 | -0.35% | $5.74B | 10.47 | 1.25% | +1.2% | D 34 | |
| Novo-Nordisk A/SNVO | 40.31 | +0.02% | $179.98B | 10.54 | 4.39% | -7.5% | D 22 |
Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.